Form SD Medtronic plc
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/8/2026
- S&P 500, Dow set to open lower as Gulf tensions send oil to over six-week high
- Brent crude hits six-week high near $97 as Houthi strike targets Saudi Aramco
- Qualcomm stock surges 9.5% on Amazon AI deal & 25M share warrant
- Energy stocks rise premarket as oil prices climb on Middle East supply fears
- Novartis shares plunge 10% as failed drug trial clouds growth outlook
- Citi initiates UiPath coverage with Buy rating and $23 target
- Trump says Canada's Bombardier must build jets in US or lose market access
- WestPark Capital Starts Akebia Therapeutics (AKBA) at Buy
- European shares subdued as surging crude sharpens focus on ECB rate path
- S&P 500, Dow set to open lower as Gulf tensions send oil to over six-week high
- After-Hours Movers: LULU, IOT, PATH, DOCU, ASAN, GWRE, ZS, PL, SWBI, OXM
- After-Hours Movers: AVGO, SNOW, HPE, NTAP, NTSK, CHPT, FIVE, TLYS, PVH, RARE
- After-Hours Movers: DELL, PANW, GTLB, CRDO, MDB, HPE, SMCI
- After-Hours Movers: WDAY, ADSK, S, RBRK, MRVL, ULTA, GAP, AFRM
- After-Hours Movers: NVDA, CRM, SNPS, CRWD, OKTA, NTNX
RBC Capital Reiterates Sector Perform Rating on Medtronic, Inc. (MDT)
May 24, 2024 6:16 AM EDTRBC Capital analyst Shagun Singh reiterated a Sector Perform rating and $92.00 price target on Medtronic, Inc. (NYSE: MDT).
The analyst comments "MDT delivered a beat (upside surprise of 1.7%/0.7% on sales/EPS, respectively), but FY25 guidance was in-line and FQ1 modestly below, sending... More
Medtronic, Inc. (MDT) PT Raised to $105 at Wells Fargo
May 24, 2024 5:20 AM EDTWells Fargo analyst Larry Biegelsen raised the price target on Medtronic, Inc. (NYSE: MDT) to $105.00 (from $102.00) while maintaining a Overweight rating.
The analyst comments "Strong FQ4 rev beat, but elevated opex drives muted EPS beat. MDT reported FQ4 2024 rev of $8.59B (+5.4% organic)... More
Medtronic, Inc. (MDT) PT Raised to $76 at UBS
May 24, 2024 4:59 AM EDTUBS analyst Danielle Antalffy raised the price target on Medtronic, Inc. (NYSE: MDT) to $76.00 (from $75.00) while maintaining a Sell rating.
The analyst comments "Despite Outperformance, We Remain Skeptical of Sustainability of New Product Momentum; Commentary Suggests FY25 Consensus EPS Possibly... More
Stifel Reiterates Buy Rating on Medtronic, Inc. (MDT)
May 23, 2024 4:25 PM EDTStifel analyst Rick Wise reiterated a Buy rating and $100.00 price target on Medtronic, Inc. (NYSE: MDT).
The analyst comments "Notching a sixth consecutive mid-single-digit top-line revenue growth quarter (+5.4% organic), Medtronics 18 months of more-consistent performance positively suggest stable underlying business fundamentals. Now starting FY2025... More
